Study of Open Label Losartan in COVID-19

NCT04335123 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Losartan

Sponsor

University of Kansas Medical Center